A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers

Trial Profile

A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 16 May 2017

At a glance

  • Drugs Brivaracetam (Primary) ; Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 11 May 2017 Status changed from completed to recruiting.
    • 28 Apr 2017 Results comparing the entrance rate of brivaracetam with levetiracetam presented at the 69th Annual Meeting of the American Academy of Neurology.
    • 11 May 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top